Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis

Alzheimer's disease (AD) is a major public health challenge, with its onset occurring years before symptoms appear. Soluble amyloid-β (Aβ) oligomers are key species in AD pathogenesis and diagnosis, highlighting the need for early detection. This study investigates the intrinsic fluorescence of Aβ(1...

Full description

Bibliographic Details
Authors: Novo, Mercedes; Illodo Brea, Sara; Seijas Cerceda, Jesús; Moraes, Stella Hernández Faria De; Rodríguez-Prieto, Flor; Al-Soufi, Wajih
Format: Article
Publication date:2025
Country:España
Institution:Universidad de Santiago de Compostela (USC)
Repository:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Language:English
OAI Identifier:oai:minerva.usc.gal:10347/43532
Online Access:https://hdl.handle.net/10347/43532
Access Level:Open access
Keyword:Alzheimer’s disease
Soluble amyloid-b (Ab) oligomers
Pathogenesis
diagnosis
_version_ 1878742113080836096
author Novo, Mercedes
author2 Illodo Brea, Sara
Seijas Cerceda, Jesús
Moraes, Stella Hernández Faria De
Rodríguez-Prieto, Flor
Al-Soufi, Wajih
author2_role author
author
author
author
author
author_browse Al-Soufi, Wajih
Illodo Brea, Sara
Moraes, Stella Hernández Faria De
Novo, Mercedes
Rodríguez-Prieto, Flor
Seijas Cerceda, Jesús
author_facet Novo, Mercedes
Illodo Brea, Sara
Seijas Cerceda, Jesús
Moraes, Stella Hernández Faria De
Rodríguez-Prieto, Flor
Al-Soufi, Wajih
author_role author
collection Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
description Alzheimer's disease (AD) is a major public health challenge, with its onset occurring years before symptoms appear. Soluble amyloid-β (Aβ) oligomers are key species in AD pathogenesis and diagnosis, highlighting the need for early detection. This study investigates the intrinsic fluorescence of Aβ(1–40) (Aβ40) as a label-free approach to detecting early-stage oligomers. Aβ40 exhibits autofluorescence dominated by tyrosine emission, which undergoes a strong blue shift and quenching during oligomerization. Additionally, aggregation-induced emission (AIE) in the visible spectral region emerges, correlating with Aβ oligomer concentration and providing a means to detect and quantify oligomers. At the critical aggregation concentrations cac1 = 0.5 μM and cac2 = 19 μM, distinct aggregation behaviours are observed. By employing steady-state fluorescence spectroscopy, a widely accessible technique, these findings establish a direct link between early Aβ aggregation and intrinsic fluorescence changes. This approach eliminates the need for extrinsic probes, simplifying experimental procedures and reducing artefacts. Although further studies are required to develop a robust quantitative correlation for potential diagnostic applications, Aβ autofluorescence represents a promising strategy for investigating early aggregation processes in the context of AD
eu_rights_str_mv openAccess
format article
id ES_f04f4dfb3aa9e1aa6dc35ebbfaebca0b
institution Universidad de Santiago de Compostela (USC)
instname_str Universidad de Santiago de Compostela (USC)
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:minerva.usc.gal:10347/43532
publishDate 2025
publishDateSort 2025
publisher Royal society of chemistry
publisherStr Royal society of chemistry
reponame_str Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
spelling Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis Novo, Mercedes Illodo Brea, Sara Seijas Cerceda, Jesús Moraes, Stella Hernández Faria De Rodríguez-Prieto, Flor Al-Soufi, Wajih Alzheimer’s disease Soluble amyloid-b (Ab) oligomers Pathogenesis diagnosis Alzheimer's disease (AD) is a major public health challenge, with its onset occurring years before symptoms appear. Soluble amyloid-β (Aβ) oligomers are key species in AD pathogenesis and diagnosis, highlighting the need for early detection. This study investigates the intrinsic fluorescence of Aβ(1–40) (Aβ40) as a label-free approach to detecting early-stage oligomers. Aβ40 exhibits autofluorescence dominated by tyrosine emission, which undergoes a strong blue shift and quenching during oligomerization. Additionally, aggregation-induced emission (AIE) in the visible spectral region emerges, correlating with Aβ oligomer concentration and providing a means to detect and quantify oligomers. At the critical aggregation concentrations cac1 = 0.5 μM and cac2 = 19 μM, distinct aggregation behaviours are observed. By employing steady-state fluorescence spectroscopy, a widely accessible technique, these findings establish a direct link between early Aβ aggregation and intrinsic fluorescence changes. This approach eliminates the need for extrinsic probes, simplifying experimental procedures and reducing artefacts. Although further studies are required to develop a robust quantitative correlation for potential diagnostic applications, Aβ autofluorescence represents a promising strategy for investigating early aggregation processes in the context of AD Royal society of chemistry https://hdl.handle.net/10347/43532
spellingShingle Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
Novo, Mercedes
Alzheimer’s disease
Soluble amyloid-b (Ab) oligomers
Pathogenesis
diagnosis
title Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
title_full Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
title_fullStr Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
title_full_unstemmed Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
title_short Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
title_sort Intrinsic visible emission of amyloid-β oligomers: a potential tool for early alzheimer's diagnosis
topic Alzheimer’s disease
Soluble amyloid-b (Ab) oligomers
Pathogenesis
diagnosis
topic_facet Alzheimer’s disease
Soluble amyloid-b (Ab) oligomers
Pathogenesis
diagnosis
url https://hdl.handle.net/10347/43532